Treatment of colorectal cancer

Annales Chirurgiae et Gynaecologiae

Volumn 89, Issue 3, 2000, Pages 216-220

  Pahlman, L ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adjuvant treatment; Colorectal cancer; Surgery

Indexed keywords

ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; REVIEW; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT INDICATION;

ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; IMMUNOTHERAPY; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; LAPAROSCOPY; LYMPH NODE EXCISION; MALE; META-ANALYSIS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 30344447004     PISSN: 03559521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Impact of variability among surgeons on postoperative morbidity and ultimate survival
2. Prognostic factor of rectum carcinoma - Experience of the German multicentre study SGCRC
3. Reappraisal of the 5 centimetre rule of distant excision for carcinoma of the rectum: A study of distal intramural spread and of patients' survival
4. Rationale for extent of lymph node dissection for right colon cancer
5. Survival after high or low ligation of the inferior mesenteric artery during curative surgery for rectal cancer
6. Curative resection for left colonic carcinoma: Hemicolectomy vs. segmental colectomy: A prospective, controlled, multicenter trial
7. Total mesorectal excision is optimal surgery for rectal cancer: A Scandinavian consensus
8. Role of circumferential margin involvement in the local recurrence of rectal cancer
9. Local recurrence following total mesorectal excision for rectal cancer
10. Improved survival in patients with rectal cancer: A population based register study
11. Effects of extended systematic lymphadenectomy for adenocarcinoma of the rectum - Significant improvement of survival rate and decrease of local recurrence
12. Total mesorectal excision and local recurrence: A study of tumour spread in the mesorectum distal to rectal cancer
13. Randomized comparison of straight and colonic J-pouch anastomosis after low anterior resection
14. Functional outcome after low anterior resection with low anastomosis for rectal cancer using the colonic J-pouch. Prospective randomized study for determination of optimum pouch size
15. Laparoscopic bowel resection in the rat: Improved postoperative recovery and less tumour take
16. The problem of port-site metastases after laparoscopic cancer surgery
17. Radiotherapy
18. Radiotherapy in addition to radical surgery for rectal cancer - Evidence for a dose-response effect favouring preoperative treatment
19. Pre- and postoperative radiotherapy in rectal carcinoma: Report from a randomized multicenter trial
20. Effective surgical adjuvant therapy for high-risk rectal carcinoma
21. SRCT (Swedish Rectal Cancer Trial): Improved survival with preoperative radiotherapy resectable rectal carcinoma
22. Experimental studies on interactions of radiation and cancer chemo-therapeutic drugs in normal tissues and a solid tumour
23. Preoperative irradiation with and without chemotherapy (MFL) in the treatment of primarily nonresectable adenocarcinoma of the rectum. Results from two consecutive studies
24. Fluorouracil, leucovorin and levamisole adjuvant therapy for colon cancer; four-year results of INT- 0089
25. Single-agent chemotherapy of colorectal cancer
26. A randomised controlled trial of adjuvant portal vein cytotoxic liver perfusion of colorectal cancer
27. Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: A randomized phase II placebo-controlled study
28. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B vs dukes' C colon cancer: Results from four NSABP adjuvant studies
29. Randomised trial of monoclonal antibody for adjuvant treatment of resected Dukes C colorectal carcinoma